azacitidine,magrolimab
gilead
['mds', 'magrolimab', 'aza ']
very interesting data on magrolimab + aza in high risk mds presented by dr. sallman in #eha2022 . especially promising for tp53 mutated patients where there is no clear standard of care yet 
Mamá de Pedro y Santiago, Esposa de Pablo, Hematóloga